Log in
Enquire now
Biogen

Biogen

A biotechnology company with a focus on treatments for neurological and neurodegenerative diseases. It was founded in 1978 and has headquarters in Cambridge, Massachusetts.

OverviewStructured DataIssuesContributors

Contents

ProductsTimelineTable: Funding RoundsTable: ProductsTable: AcquisitionsTable: SBIR/STTR AwardsTable: PatentsTable: Further ResourcesReferences
biogen.uk.com
biogen.com
biogen.co.jp...me.html
biogen-international.com
biogen.co.jp
...
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Technology
Technology
Pharmaceutical industry
Pharmaceutical industry
Loading...
Drug discovery
Drug discovery
Biomanufacturing
Biomanufacturing
Advanced Manufacturing
Advanced Manufacturing
Biomedical engineering
Biomedical engineering
Loading...
...
Location
Japan
Japan
United Kingdom
United Kingdom
Tokyo
Tokyo
United States
United States
Cambridge, Massachusetts
Cambridge, Massachusetts
8
Switzerland
Switzerland
North Carolina
North Carolina
Morrisville, North Carolina
Morrisville, North Carolina
...
B2X
B2B
B2B
CEO
Michel Vounatsos
Michel Vounatsos
Founder
Charles Weissmann
Charles Weissmann
Phillip Allen Sharp
Phillip Allen Sharp
Kenneth Murray (biologist)
Kenneth Murray (biologist)
Walter Gilbert
Walter Gilbert
Pitchbook URL
pitchbook.com/profiles.../10553-05
Parent Organization
‌
Renaissance Technologies
Biogen
Biogen
Subsidiary
Biogen
Biogen
Nightstar Therapeutics Limited
Nightstar Therapeutics Limited
Spinout
‌
Bioverativ
Number of Employees (Ranges)
5,001 – 10,000
Email Address
publicaffairs.eu@biogen.com8
ir@biogen.com8
japan-pa@biogen.com
Japan-PA@biogen.com
ukreception@biogen.com
public.affairs@biogen.com8
Phone Number
+184447746728
+178146432608
+186663346368
+178146424428
+183342593608
+180045622558
+41413921700
+441628501010
Full Address
225 Binney Street Cambridge, MA 02142, USA8
CIK Number
875,045
Place of Incorporation
Delaware
Delaware
Investors
Ridgeback Capital
Ridgeback Capital
DUNS Number
121376230
IRS Number
330,112,644
Founded Date
1978
Competitors
Cortexyme
Cortexyme
GC Therapeutics
GC Therapeutics
AVA Biochem
AVA Biochem
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Amgen
Amgen
7
Stock Symbol
BIIB10
Exchange
Nasdaq
Nasdaq
10
Former CEO
George A. Scangos
George A. Scangos
Patents Assigned (Count)
349
Legal Entity Identifier
W8J5WZB5IY3K0NDQT6719
Country
Japan
Japan
United States
United States
Headquarters
Cambridge, Massachusetts
Cambridge, Massachusetts

Other attributes

Company Operating Status
Active
Invested in
CAMP4 Therapeutics
CAMP4 Therapeutics
Solid Biosciences
Solid Biosciences
Ataxion
Ataxion
Market Capitalization
37,540,000,000
Short Name
Biogen9
SIC Code
2,836
Wikidata ID
Q864338

Biogen is a United States-based company in the pharmaceutical industry that researches, develops, and delivers therapies for people living with serious neurological and neurodegenerative diseases. It has other locations world wide including Denmark and Switzerland. It has the stated goal of delivering therapies for its patients as well as investing in areas of highest return to deliver long-term value to its stockholders.

Products

The company manufactures therapies and medicines for diseases such as Parkinson's, Spinal Muscular Atrophy, and Multiple Sclerosis. It also researches solutions for other diseases such as Lupus, Epilepsy, and Schizophrenia. Biogen's drug aducanumab is under review by the Federal Drug Administration and has shown evidence of having the capability of reducing medical conditions that can cause Alzheimer's.

In March 2020, Biogen partnered with Vir to research and manufacture therapies for COVID-19. With the antibody development and manufacturing pact made between the two companies, Biogen would play the role of manufacturing and Vir has researched and developed the antibodies.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

A quarter century of investment and innovation in Alzheimer's

https://youtu.be/gFZS_Eh48VQ

Web

May 6, 2021

Biogen signs on to manufacture clinical supplies for Vir's COVID-19 antibodies

Eric Sagonowsky

https://www.fiercepharma.com/manufacturing/biogen-signs-to-develop-manufacture-vir-antibodies-for-covid-19

Web

March 12, 2020

Biomarkers | Technology that is changing neuroscience

https://youtu.be/7BEqs_eFjd8

Web

December 10, 2021

Bloomberg - Are you a robot?

Bailey Lipschultz

https://www.bloomberg.com/news/articles/2020-03-07/biogen-investors-face-next-test-in-gamble-on-alzheimer-s-disease

Web

References

Find more companies like Biogen

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.